Move faster. Reduce uncertainty. Build stronger drug IP.
SandboxAQ applies quantitative AI grounded in physics and chemistry to guide real-world drug discovery and R&D decisions. Biopharma teams use these models to accelerate discovery, improve predictability, and make higher-confidence development choices. Meet with SandboxAQ during JPM Week to see how this approach is being deployed today, including work with partners such as Sanofi and MapLight.
Jack Hidary, CEO of SandboxAQ, will be speaking at the J.P. Morgan Healthcare Conference on how quantitative AI is shaping the next phase of drug discovery and development.
January 14 | 7:30–9:00 AM | MassBio and Termeer Institute: CEO & Founder Link | Parc 55 Hotel
January 15 | 10:00–10:25 AM | The Westin St. Francis
How AI is transforming energy & biotech | Jack Hidary on Bloomberg TV
MapLight brightens SandboxAQ with new deal to discover new CNS candidates
MapLight partners with SandboxAQ in $200M neuro drug development deal
Molecules, Models, and the Quiet Reinvention of Drug Discovery
AI Models Enhance the Drug Discovery Portfolio
Bahrain's Mumtalakat teams up with SandboxAQ to create biotech assets valued at $1bn
Structure-aware AI is setting a new pace for drug discovery
Alphabet's SandboxAQ teams up with Florida biotech to develop mRNA cancer vaccine
Large quantitative models: How AI is accelerating drug discovery
How Large Quantitative Models Are Shaping the Future Of Drug Discovery
Accelerating Antibody Optimization with Scalable Pharmacological Modeling and Drug Discovery Software
SAIR: the Structurally Augmented IC50 Repository
SandboxAQ: Accelerating Drug Discovery Through Cloud Integration
Large Quantitative Models vs. Large Language Models: What’s the Difference?
Navigating the Drug Discovery Labyrinth: Large Quantitative Models as Our Map in Target Identification
LQMs: A new era of drug discovery and drug development?
SandboxAQ and MapLight Therapeutics Announce Strategic Collaboration to Discover and Develop Novel CNS Therapies
SandboxAQ Contributes to OpenFold Consortium’s Newly Released OpenFold3 Model
Mumtalakat and SandboxAQ Announce Strategic Partnership to Catalyse Bahrain’s Biotech Ecosystem
SandboxAQ and iOncologi Partner to Accelerate Brain Cancer Treatment with AI-driven Drug Discovery For Glioblastoma
SandboxAQ Unveils SAIR, a Novel Open Dataset of Protein-Ligand Structures Labelled By Binding Affinities
Stand Up To Cancer and SandboxAQ Launch Collaboration to Advance Treatment Innovation
SandboxAQ Unlocks New Capabilities for Scientific Discovery and Enterprise Innovation with NVIDIA DGX Cloud
